Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Drajer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Cardiovascular Electrophysiology|June 1, 1994
Bedside recording of His potentialsS Drajer, R Pesce, E M Valero
Medicina|March 1, 1973
[Induction of auricular fibrillation during cardioversion in patients with atrial flutter. Auricular vulnerable period]J Neuman, J Wigutov, R Pesce, et al.
European Journal of Clinical Pharmacology|June 19, 1978
Acute double blind trial of a new anti-anginal drug: molsidomineS Guerchicoff, A Vazquez, H Kunik, et al.
Medicina|January 1, 1996
[Pathology of cardiac lesions induced by radiofrequency ablation in an experimental model]S Drajer, R Beigelman, M I Robles Urquiza, et al.
American Heart Journal|March 1, 1985
Molsidomine in the treatment of acute heart failureS Drajer, A Vazquez, H Cercós, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarctionS Drajer, H Cercós, H Torres, et al.
Circulation|September 1, 1987
Beneficial effects of timolol on infarct size and late ventricular tachycardia in patients with acute myocardial infarctionF Roqué, L M Amuchastegui, M A Lopez Morillos, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Cardiovascular Electrophysiology|June 1, 1994
Bedside recording of His potentialsS Drajer, R Pesce, E M Valero
Medicina|March 1, 1973
[Induction of auricular fibrillation during cardioversion in patients with atrial flutter. Auricular vulnerable period]J Neuman, J Wigutov, R Pesce, et al.
European Journal of Clinical Pharmacology|June 19, 1978
Acute double blind trial of a new anti-anginal drug: molsidomineS Guerchicoff, A Vazquez, H Kunik, et al.
Medicina|January 1, 1996
[Pathology of cardiac lesions induced by radiofrequency ablation in an experimental model]S Drajer, R Beigelman, M I Robles Urquiza, et al.
American Heart Journal|March 1, 1985
Molsidomine in the treatment of acute heart failureS Drajer, A Vazquez, H Cercós, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarctionS Drajer, H Cercós, H Torres, et al.
Circulation|September 1, 1987
Beneficial effects of timolol on infarct size and late ventricular tachycardia in patients with acute myocardial infarctionF Roqué, L M Amuchastegui, M A Lopez Morillos, et al.
Pageof 1